tiprankstipranks
Cyclerion Therapeutics,Inc. (CYCN)
NASDAQ:CYCN
US Market

Cyclerion Therapeutics (CYCN) Ownership - Who Owns Cyclerion Therapeutics?

151 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 11, 2023Sold$27

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
357,880Institution13.21%1,048,588
41,864Institution1.54%122,662
40,531Institution1.50%118,756
32,351Institution1.19%94,788
23,490Institution0.87%68,826
16,885Institution0.62%49,473
13,840Institution0.51%40,551
5,350Institution0.20%15,676
3,789Institution0.14%11,102
209Institution<0.01%612

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
41,864Institution1.54%122,662
40,531Institution1.50%118,756
32,351Institution1.19%94,788
16,885Institution0.62%49,473
5,350Institution0.20%15,676
3,789Institution0.14%11,102
209Institution<0.01%612

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
23,490Institution0.87%75,168
13,840Institution0.51%43,596

FAQ

Who Owns Cyclerion Therapeutics,Inc. (CYCN)?
Currently, no data Available
What percentage of Cyclerion Therapeutics,Inc. (CYCN) stock is held by institutional investors?
Currently, no data Available
What percentage of Cyclerion Therapeutics,Inc. (CYCN) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Cyclerion Therapeutics,Inc. (CYCN)?
David Gerald Greenspan owns the most shares of Cyclerion Therapeutics,Inc. (CYCN).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis